How the patient with the type 2 diabetes mellitus previously treated with a combination of premixed insulins profited from a switch to insulin glargine 300 U/mL
2018
Abstract
A case report describes a patient with a prolonged inadequate compensation of diabetes, in whom the first combined product that employs the effect of a long-acting insulin and GLP-1 analogue was used. The patient responded to a newly initiated treatment very well.